BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 24890564)

  • 41. Design, synthesis, antimicrobial evaluation and molecular docking studies of some new thiophene, pyrazole and pyridone derivatives bearing sulfisoxazole moiety.
    Nasr T; Bondock S; Eid S
    Eur J Med Chem; 2014 Sep; 84():491-504. PubMed ID: 25050881
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structure-activity relationships of new cyanothiophene inhibitors of the essential peptidoglycan biosynthesis enzyme MurF.
    Hrast M; Turk S; Sosič I; Knez D; Randall CP; Barreteau H; Contreras-Martel C; Dessen A; O'Neill AJ; Mengin-Lecreulx D; Blanot D; Gobec S
    Eur J Med Chem; 2013 Aug; 66():32-45. PubMed ID: 23786712
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis, in vitro evaluation, and molecular docking studies of azetidinones and thiazolidinones of 2-amino-5-cyclopropyl-1,3,4-thiadiazole as antibacterial agents.
    Patel H; Mishra L; Noolvi M; Karpoormath R; Cameotra SS
    Arch Pharm (Weinheim); 2014 Sep; 347(9):668-84. PubMed ID: 25066774
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Murgocil is a highly bioactive staphylococcal-specific inhibitor of the peptidoglycan glycosyltransferase enzyme MurG.
    Mann PA; Müller A; Xiao L; Pereira PM; Yang C; Ho Lee S; Wang H; Trzeciak J; Schneeweis J; Dos Santos MM; Murgolo N; She X; Gill C; Balibar CJ; Labroli M; Su J; Flattery A; Sherborne B; Maier R; Tan CM; Black T; Onder K; Kargman S; Monsma FJ; Pinho MG; Schneider T; Roemer T
    ACS Chem Biol; 2013 Nov; 8(11):2442-51. PubMed ID: 23957438
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 4-Substituted thieno[2,3-d]pyrimidines as potent antibacterial agents: Rational design, microwave-assisted synthesis, biological evaluation and molecular docking studies.
    Gill RK; Singh H; Raj T; Sharma A; Singh G; Bariwal J
    Chem Biol Drug Des; 2017 Dec; 90(6):1115-1121. PubMed ID: 28544494
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and in vitro antimycobacterial activity of balofloxacin ethylene isatin derivatives.
    Feng LS; Liu ML; Wang B; Chai Y; Hao XQ; Meng S; Guo HY
    Eur J Med Chem; 2010 Aug; 45(8):3407-12. PubMed ID: 20493593
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis and evaluation of in vivo antioxidant, in vitro antibacterial, MRSA and antifungal activity of novel substituted isatin N-(2,3,4,6-tetra-O-acetyl-β-d-glucopyranosyl)thiosemicarbazones.
    Thanh ND; Giang NTK; Quyen TH; Huong DT; Toan VN
    Eur J Med Chem; 2016 Nov; 123():532-543. PubMed ID: 27517802
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and on-target antibacterial activity of novel 3-elongated arylalkoxybenzamide derivatives as inhibitors of the bacterial cell division protein FtsZ.
    Ma S; Cong C; Meng X; Cao S; Yang H; Guo Y; Lu X; Ma S
    Bioorg Med Chem Lett; 2013 Jul; 23(14):4076-9. PubMed ID: 23770057
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Design, synthesis ADMET and molecular docking of new imidazo[4,5-b]pyridine-5-thione derivatives as potential tyrosyl-tRNA synthetase inhibitors.
    Othman IMM; Gad-Elkareem MAM; Hassane Anouar E; Aouadi K; Kadri A; Snoussi M
    Bioorg Chem; 2020 Sep; 102():104105. PubMed ID: 32717689
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Design, synthesis and structure-based optimization of novel isoxazole-containing benzamide derivatives as FtsZ modulators.
    Bi F; Song D; Zhang N; Liu Z; Gu X; Hu C; Cai X; Venter H; Ma S
    Eur J Med Chem; 2018 Nov; 159():90-103. PubMed ID: 30268826
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Discovery of novel non-peptide inhibitors of BACE-1 using virtual high-throughput screening.
    Yi Mok N; Chadwick J; Kellett KA; Hooper NM; Johnson AP; Fishwick CW
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6770-4. PubMed ID: 19854048
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anti-tyrosinase, antioxidant, and antibacterial activities of novel 5-hydroxy-4-acetyl-2,3-dihydronaphtho[1,2-b]furans.
    Xia L; Idhayadhulla A; Lee YR; Wee YJ; Kim SH
    Eur J Med Chem; 2014 Oct; 86():605-12. PubMed ID: 25218909
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adenosine analogs as inhibitors of tyrosyl-tRNA synthetase: Design, synthesis and antibacterial evaluation.
    Wei W; Shi WK; Wang PF; Zeng XT; Li P; Zhang JR; Li Q; Tang ZP; Peng J; Wu LZ; Xie MQ; Liu C; Li XH; Wang YC; Xiao ZP; Zhu HL
    Bioorg Med Chem; 2015 Oct; 23(20):6602-11. PubMed ID: 26404408
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Peptidoglycan glycosyltransferase-ligand binding assay based on tryptophan fluorescence quenching.
    Dahmane I; Montagner C; Matagne A; Dumbre S; Herdewijn P; Terrak M
    Biochimie; 2018 Sep; 152():1-5. PubMed ID: 29909047
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Affinity-Based Screen for Inhibitors of Bacterial Transglycosylase.
    Wu WS; Cheng WC; Cheng TR; Wong CH
    J Am Chem Soc; 2018 Feb; 140(8):2752-2755. PubMed ID: 29411975
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structure-Activity Relationships of Novel Tryptamine-Based Inhibitors of Bacterial Transglycosylase.
    Sosič I; Anderluh M; Sova M; Gobec M; Mlinarič Raščan I; Derouaux A; Amoroso A; Terrak M; Breukink E; Gobec S
    J Med Chem; 2015 Dec; 58(24):9712-21. PubMed ID: 26588190
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Functional and structural analysis of a key region of the cell wall inhibitor moenomycin.
    Fuse S; Tsukamoto H; Yuan Y; Wang TS; Zhang Y; Bolla M; Walker S; Sliz P; Kahne D
    ACS Chem Biol; 2010 Jul; 5(7):701-11. PubMed ID: 20496948
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Design, synthesis and biological activity evaluation of novel 2,6-difluorobenzamide derivatives through FtsZ inhibition.
    Bi F; Guo L; Wang Y; Venter H; Semple SJ; Liu F; Ma S
    Bioorg Med Chem Lett; 2017 Feb; 27(4):958-962. PubMed ID: 28082038
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tackling Microbial Resistance with Isatin-Decorated Thiazole Derivatives: Design, Synthesis, and in vitro Evaluation of Antimicrobial and Antibiofilm Activity.
    Kassab RM; Al-Hussain SA; Elleboudy NS; Albohy A; Zaki MEA; Abouzid KAM; Muhammad ZA
    Drug Des Devel Ther; 2022; 16():2817-2832. PubMed ID: 36046334
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Design and synthesis of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III (FabH) as potential antibacterial agents.
    Shi L; Fang RQ; Zhu ZW; Yang Y; Cheng K; Zhong WQ; Zhu HL
    Eur J Med Chem; 2010 Sep; 45(9):4358-64. PubMed ID: 20557983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.